Skip to content
10-Q

Quarterly Report

Orchestra BioMed Holdings, Inc. OBIO

0001558370-24-015313

← back to feed
Filed
Nov 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 7, 2024 38.01M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $25.61M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $30.56M
Current Liabilities Q3 2024 · Sep 30, 2024 $16.22M
Current Liabilities Q3 2024 · Dec 31, 2023 $11.21M
Total Liabilities Q3 2024 · Sep 30, 2024 $29.1M
Total Liabilities Q3 2024 · Dec 31, 2023 $27.17M
Current Assets Q3 2024 · Sep 30, 2024 $68.55M
Current Assets Q3 2024 · Dec 31, 2023 $89.11M
Total Assets Q3 2024 · Sep 30, 2024 $75.32M
Total Assets Q3 2024 · Dec 31, 2023 $95.21M
Shares Diluted Q3 2024 · Sep 30, 2023 35.24M sh
Shares Diluted Q3 2024 · Sep 30, 2023 32.59M sh
Capex Q3 2024 · Sep 30, 2023 $81K
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$35.15M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.38
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.11
Eps Basic Q3 2024 · Sep 30, 2023 −$0.38
Eps Basic Q3 2024 · Sep 30, 2023 −$1.11
Sga Expense Q3 2024 · Sep 30, 2023 $6.34M
Sga Expense Q3 2024 · Sep 30, 2023 $16.07M
Rd Expense Q3 2024 · Sep 30, 2023 $8.56M
Rd Expense Q3 2024 · Sep 30, 2023 $25.31M
Net Income Q3 2024 · Sep 30, 2023 −$13.32M
Net Income Q3 2024 · Sep 30, 2023 −$36.3M
Net Income Q3 2024 · Jun 30, 2023 −$12.05M
Net Income Q3 2024 · Mar 31, 2023 −$10.94M
Operating Income Q3 2024 · Sep 30, 2023 −$14.52M
Operating Income Q3 2024 · Sep 30, 2023 −$39.03M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $41K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $139K
Revenue Q3 2024 · Sep 30, 2023 $419K
Revenue Q3 2024 · Sep 30, 2023 $2.5M